Jazz Pharmaceuticals (JAZZ) on Watch Following Tweet by Shkreli

September 1, 2016 3:00 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Jazz Pharmaceuticals (NASDAQ: JAZZ) shares were in focus Thursday following a positive mentioned by Martin Shkreli. He thinks shares are worth double the current stock price.




Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Trader Talk

Add Your Comment